Delving into the details, we found 51% of traders were bullish, while 25% showed bearish tendencies. Out of all the trades we ...

Ahead of his confirmation hearing this week, Robert F. Kennedy Jr., President Donald Trump’s nominee for HHS Secretary, has ...

As of market close on Friday, Jan. 24, Moderna stock is up 21.6% this week. Here's why.

Moderna wins EU tender to supply COVID-19 vaccines for up to four years, offering diverse formats like prefilled syringes to ...

Last year, a number of new records were set, and today, we take a look at some of the top trading trends from 2024. Markets rallied to new all-time highs. As interest rates fell, ...

Agreement,: Moderna will supply its mRNA COVID-19 vaccine to 17 participating countries in the EU, Norway, and North ...

The Agreement provides participating countries with the opportunity to diversify their mRNA COVID-19 vaccine supply and gain access to pre-filled syringe vaccine formats CAMBRIDGE, MA / ACCESS Newswir ...

No person-to-person spread has been detected, but that doesn’t mean an H5N1 avian influenza pandemic isn’t possible or even ...

To get a sense of who is truly in control of Moderna, Inc. ( NASDAQ:MRNA ), it is important to understand the ownership structure of the business. With 69% stake, institutions possess the maximum ...

The article " After a Reset Year, Is Moderna Stock Poised for a Comeback? " first appeared on MarketBeat.

Merck shares trade at a significant discount to peers. The company faces challenges, but there are reasons to be bullish.

Analysts at Brookline Capital Management reduced their FY2024 EPS estimates for Moderna in a note issued to investors on Monday, January 13th. Brookline Capital Management analyst L. Cann now ...